BIOMAT Database Logo BIOMAT Database Logo

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. 1992

F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Department of Genetics, Biology and Medical Chemistry, University of Torino.

Hepatocyte Growth Factor (HGF, also known as Scatter Factor) is a powerful mitogen or motility factor in different cells, acting through the tyrosine kinase receptor encoded by the MET protooncogene. Endothelial cells express the MET gene and expose at the cell surface the mature protein (p190MET) made of a 50 kD (alpha) subunit disulfide linked to a 145-kD (beta) subunit. HGF binding to endothelial cells identifies two sites with different affinities. The higher affinity binding site (Kd = 0.35 nM) corresponds to the p190MET receptor. Sub-nanomolar concentrations of HGF, but not of a recombinant inactive precursor, stimulate the receptor kinase activity, cell proliferation and motility. HGF induces repairs of a wound in endothelial cell monolayer. HGF stimulates the scatter of endothelial cells grown on three-dimensional collagen gels, inducing an elongated phenotype. In the rabbit cornea, highly purified HGF promotes neovascularization at sub-nanomolar concentrations. HGF lacks activities related to hemostasis-thrombosis, inflammation and endothelial cells accessory functions. These data show that HGF is an in vivo potent angiogenic factor and in vitro induces endothelial cells to proliferate and migrate.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
July 2001, Biochemical and biophysical research communications,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
June 2001, Biochemical and biophysical research communications,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Which cell is transferred hepatocyte growth factor gene?
April 2007, The Journal of thoracic and cardiovascular surgery,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Vascular endothelial growth factor, a potent and selective angiogenic agent.
January 1996, The Journal of biological chemistry,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor.
June 2004, American journal of physiology. Lung cellular and molecular physiology,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
December 2003, Journal of neuroscience research,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Vascular endothelial growth factor (VEGF)-D stimulates VEGF-A, stanniocalcin-1, and neuropilin-2 and has potent angiogenic effects.
July 2011, Arteriosclerosis, thrombosis, and vascular biology,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.
November 2003, The Journal of biological chemistry,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
PDGF-D is a potent transforming and angiogenic growth factor.
March 2003, Oncogene,
F Bussolino, and M F Di Renzo, and M Ziche, and E Bocchietto, and M Olivero, and L Naldini, and G Gaudino, and L Tamagnone, and A Coffer, and P M Comoglio
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
August 1987, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!